DC Vaccination Induces Antigen Specific Immune Responses in AML Patients: A 1-Year Interim Assessment
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-129749
Abstract: Acute myeloid leukemia (AML) is a lethal hematological malignancy characterized by high rates of relapse (50%). Studies of immune responses in AML patients led to identification of two leukemia-associated antigens (Wilms' tumor protein 1 (WT1)… read more here.
Keywords: aml patients; prame; wt1 prame; gmbh employment ... See more keywords